| __timestamp | Axsome Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 855506000 |
| Thursday, January 1, 2015 | 6776987 | 996170000 |
| Friday, January 1, 2016 | 21199860 | 1047690000 |
| Sunday, January 1, 2017 | 19957616 | 1324625000 |
| Monday, January 1, 2018 | 23495055 | 1416476000 |
| Tuesday, January 1, 2019 | 53647067 | 1754540000 |
| Wednesday, January 1, 2020 | 70244579 | 1829537000 |
| Friday, January 1, 2021 | 58060725 | 3051100000 |
| Saturday, January 1, 2022 | 57947447 | 2540300000 |
| Sunday, January 1, 2023 | 97944000 | 3162900000 |
| Monday, January 1, 2024 | 187077000 | 3630300000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and Axsome Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Since 2014, Vertex has consistently outpaced Axsome in R&D spending, with a staggering 2,300% higher average annual expenditure. In 2023, Vertex's R&D expenses peaked at approximately $3.16 billion, reflecting its robust pipeline and commitment to groundbreaking therapies.
Axsome, while starting from a modest base, has shown remarkable growth in R&D investment, increasing its spending by over 2,000% from 2014 to 2023. This surge underscores Axsome's aggressive pursuit of innovative treatments, particularly in the field of central nervous system disorders.
As these two companies continue to invest in R&D, their strategies will shape the future of biotech innovation.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.